X
19
Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is INSULIN INJECTION HUMAN BIOSYNTHETIC, with a corresponding application number 2024233 and regulatory information .
proudly manufactured in the
Novo Nordisk's NOVOLIN GE TORONTO SOLUTION, medication with 100UNIT/ML of INSULIN INJECTION HUMAN BIOSYNTHETIC.